Work

Toxicity and Early Response after Intravenous (IV) Busulfan (Bu) Plus Melphalan (Mel) Conditioning for Autologous Stem Cell Transplantation (SCT) in Patients (pts) with Multiple Myeloma (MM).

Year: 2006

Type: article

Source: Blood

DOI: 10.1182/blood.v108.11.2943.2943

Authors: Partow Kebriaei, Sergio Giralt, Timothy L. Madden, Neil Thapar, Elizabeth J. Shpall, Chitra Hosing, Muzaffar H. Qazilbash, Daniel R. Couriel, Uday Popat, Peter F. Thall, Richard E. Champlin, Roy Jones, Borje S. Andersson

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588777894

FWCI: 0.401

Cites:

Cited by: 2

Related to: 10